Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission
The majority of patients affected with lysosomal storage disorders (LSD) exhibit neurological symptoms. For mucopolysaccharidosis type IIIC (MPSIIIC), the major burdens are progressive and severe neuropsychiatric problems and dementia, primarily thought to stem from neurodegeneration. Using the MPSI...
Main Authors: | Camila Pará, Poulomee Bose, Luigi Bruno, Erika Freemantle, Mahsa Taherzadeh, Xuefang Pan, Chanshuai Han, Peter S. McPherson, Jean-Claude Lacaille, Éric Bonneil, Pierre Thibault, Claire O’Leary, Brian Bigger, Carlos Ramon Morales, Graziella Di Cristo, Alexey V. Pshezhetsky |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-08-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.142073 |
Similar Items
-
Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
by: Pan, X, et al.
Published: (2022) -
Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
by: Claire O’Leary, et al.
Published: (2023-07-01) -
Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC.
by: Xiaolian Fan, et al.
Published: (2011-01-01) -
Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC
by: Sara Marcó, et al.
Published: (2016-09-01) -
Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.
by: Hélène F E Gleitz, et al.
Published: (2017-01-01)